Loading…
Absence of viral transmission in injecting drug users in Russia
At least 100 000 cases of HIV-1 infection had been identified in Russia by March 2001, more than 90% of which were associated with injected-drug use. [...]70–90% of injecting drug users in Russia are infected with hepatitis C virus (HCV). HCV genetic subtypes 3a and la dominate among young injecting...
Saved in:
Published in: | The Lancet (British edition) 2001-09, Vol.358 (9286), p.1016-1017 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | At least 100 000 cases of HIV-1 infection had been identified in Russia by March 2001, more than 90% of which were associated with injected-drug use. [...]70–90% of injecting drug users in Russia are infected with hepatitis C virus (HCV). HCV genetic subtypes 3a and la dominate among young injecting drug users in western Europe, whereas subtype 1b is rare in individuals younger than 20 years presumed to have been infected through drug use.4 By contrast, HCV genetic subtypes 1b and 3a are the most prevalent among injecting drug users in Russia. [...]up to 13% of injecting drug users in western Europe are infected with the human T-cell leukaemia virus type II,5 whereas this virus is not present at all in this risk group in Russia. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(01)06146-3 |